BioServe will help Fox Chase provide next generation sequencing capabilities as it has developed a new internal laboratory utilizing next-generation sequencing and analysis platforms and novel biological information technology systems for advanced analysis of genomic data.
BioServe’s BioRepository contains high-quality, high-yield DNA ready for next generation sequencing analysis, besides having high quality samples ready for cancer genome analysis.
BioServe president Rama Modali said the company is happy to offer next generation sequencing through Fox Chase.
"BioServe is uniquely positioned to be a single partner that can provide high quality human tissue samples and generate validated data from those samples to accelerate discovery," Modali added.